-2%

est. 2Y upside i

Series A

The AI Operating System For Modern Fleets.

Rank

#3661

Sector

ESG / Sustainability Tech

Est. Liquidity

~5Y

Data Quality

Data: Low

Carma is a niche Series A ESG SaaS targeting a real regulatory-driven need in European private markets, but the combination of a thin moat, high incumbent threat (MSCI, S&P, ESG Book), a direct well-funded competitor in Novata, and structural ESG headwinds in the US makes this a highly asymmetric risk profile skewed to the downside.

Last updated: April 3, 2026

Bull (15%)+180%

CSRD Phase 2 enforcement in Europe (FY2026 mandatory reporting for mid-caps) creates a wave of non-discretionary demand from EU-based PE firms; Carma captures ~5–7% of its $860M SAM (~$43–60M ARR by 2028) and is acquired by MSCI, Workiva, or a financial data aggregator at 4–5x ARR (~$180–250M), representing ~3–4x on an estimated $60M current valuation — though preference-adjusted returns for common holders are meaningfully lower.

Base (35%)+25%

Carma grows steadily within the EU private markets niche — SFDR and CSRD create a captive buyer set — but US ESG headwinds and competition from better-capitalized Novata (Goldman-backed) and ESG Book (Deutsche Börse-owned) limit addressable market to EU-only, reaching ~$12–18M ARR by 2028 and a Series B or modest acquisition at ~$70–80M, barely above current valuation after dilution.

Bear (50%)-75%

US ESG backlash accelerates globally and even EU enforcement stalls; MSCI and S&P Global bundle private-markets ESG into existing institutional data subscriptions for free, destroying Carma's pricing power; growth stalls below $5M ARR, the company struggles to raise a Series B and either winds down or sells for $10–15M, with $15M in liquidation preferences absorbing most of that — common stockholders recover little or nothing.

Est. time to liquidity~5.0 years

Preference Stack Risk

high

$15M in total investor liquidation preferences sits ahead of common stockholders on an estimated ~$60M post-money valuation, meaning investors recoup ~25% of any exit proceeds before common holders see a dollar.

Dilution Risk

high

As a pre-revenue-positive Series A company needing at minimum one more major growth round, employees should expect 20–35% additional dilution before any liquidity event.

Secondary Liquidity

none

No secondary market or tender offer activity is evident for a 75-person UK-based Series A company; employees should assume zero liquidity until an M&A event or IPO, likely 5+ years away.

Questions to Ask at the Interview

Strategic questions based on Carma's data — designed to show you've done your homework.

  • 1

    “Given that Novata is explicitly backed by major institutional LPs like Goldman Sachs and Hamilton Lane — the same firms Carma is selling to — how is the team differentiating on distribution and product to compete with a competitor that already has trust relationships with the buyer set?”

  • 2

    “With CSRD Phase 2 and SFDR being the primary demand drivers, what percentage of current pipeline is EU-based vs. US-based, and how has US ESG political headwinds in 2025–26 affected new logo conversion rates?”

  • 3

    “The company is pre-profitability at 75 people with $15M total raised — what is the current runway, and what ARR milestone is the team targeting to support a Series B raise on terms that are not severely dilutive to employees?”

Community

Valuation Sentiment

Our model estimates -2% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.